tbuckley/cabot-search huggingface dataset:
P1.12B.01 Intracranial Efficacy of Lorlatinib via RANO-BM in ALK-Fusion NSCLC with CNS Metastases: A Retrospective, Multicenter Study
Authors: J. Li, Z. Wei, H. Lan, Y. Wei, J. Fan, Y. Zhu, H. Li, J. Ge
Journal: Journal of Thoracic Oncology (2024)
P1.12B.02 Mechanisms of Resistance to First-Line vs Later-Line Alectinib in ALK Fusion-Positive Non-Small Cell Lung Cancer
Authors: S. Waliany, A. Do, A. Liu, J. Peterson, A. Hata, I. Dagogo-Jack, J. Gainor, J.J. Lin
Journal: Journal of Thoracic Oncology (2024)
P2.04A.05 Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at a Large U.S. Health System: A Randomized Trial
Authors: K.L. Taylor, R.M. Williams, G. Luta, K. Davis, J.L. Frey, T. Lobo, O. Rostagni, J. Whealan, P. Yee, Z.L. Rashid, C. Stanton, R. Niaura, D. Abrams, K. Foley, H.L. Arem, J. Jayasekera, J. Slejko, L.S. Romero, C.J. Breece, N. Cobb, C. Debnam, V.L. Pham, E.D. Anderson
Journal: Journal of Thoracic Oncology (2024)
P1.12B.06 Deulorlatinib (TGRX-326)in Patients with ALK Fusion-Positive NSCLC: Update from the Phase 1 Trial
Authors: L. Zhang, H. Zhao, S. Zhao, H. Zhou, Y. Ma, N. Yang, Z. Wang, W. Jin, X. Li, Y. Liu, R. Meng, J. Zhou, Y. Cheng, Y. Wang, Z. Yu
Journal: Journal of Thoracic Oncology (2024)
P1.12A.05 Aumolertinib in Treatment-Naïve EGFR-Mutant NSCLC Patients with Brain Metastases:Efficacy and Safety Data from the ARTISTRY
Authors: X. Zhang, M. Zhang, C. Wei, X. Du, G. Zhang, Y. Niu, X. Yan, J. Yang, H. Wang
Journal: Journal of Thoracic Oncology (2024)
P2.10A.01 Phase 2 Study of Disitamab Vedotin in Patients with HER2-Expressing Non-Small Cell Lung Cancer (DV-005; Trial in Progress)
Authors: J. Riess, B. Pothuri, N. Gabrail, V. Castonguay, R.E. Sanborn, S. Kalmadi, X. Li, M. Yang, E.E. Dumbrava, J.F. Liu
Journal: Journal of Thoracic Oncology (2024)
P1.12A.03 Outcome and Transcriptomic Features of Dual EGFR and MET Blockade in NSCLC
Authors: D.D.-W. Lee, W.P. Ng, S.F. Ang, D.P. Lau, L.Y. Wang, G.G.Y. Lai, M.Y.W. Boey, T.K.H. Lim, D.S.W. Tan
Journal: Journal of Thoracic Oncology (2024)
P3.03I.17 Exploring Autophagy Flux-Related Molecules to Overcome in Acquired Resistance to EGFR TKIs in NSCLC Patients Harboring EGFR Mutations
Authors: J.-H. Kang, J.-O. Kim, M.-R. Lee, M.-Y. Kim, S. Kim, H.K. Kim, K. Lee, S.R. Baek, J.I. Kim, D. Jeon, Y.S. Lee
Journal: Journal of Thoracic Oncology (2024)
P3.13D.09 Prevalence and Prognostic Impact of SEZ6 Expression in a Real-World Cohort of Patients with Small-Cell Lung Cancer
Authors: S. Wang, A. Luo, N. Choudhury, L. Wang, D. Xu, F. Jiang, L. Roberts-Rapp, Y.C. Choi, M. Cai, N. Rudra-Ganguly, P. Ansell, L. Paz-Ares, L.A. Byers
Journal: Journal of Thoracic Oncology (2024)
P3.13D.03 Inhibition of LSD1 Prevented Tumor Progression and Recurrence to Radioimmunotherapy in Small Cell Lung Cancer
Authors: F. Na, H. Wang, X. Pan, K. Kang, Z. Yao, Y. Zheng, G. Lin, Y. Wu, R. Luo, X. Zhang, R. Tong, C. Chen, Y. Lu
Journal: Journal of Thoracic Oncology (2024)
P3.12C.01 BRAF Mutation Diversity and Impact on Clinical Outcomes in Non-Small Cell Lung Cancer
Authors: K. Lu, J.P. Shen, F.J. Lopez-Diaz, A. Leal, B.D. Woodward, V. Velcheti, J.W. Riess, A.S. Mansfield, R. Salgia, H. Husain
Journal: Journal of Thoracic Oncology (2024)
P3.12D.04 Enhanced vs Standard Dermatologic Management with Amivantamab-Lazertinib in Advanced NSCLC: Phase 2 COCOON Study
Authors: B.C. Cho, N. Girard, M.B. Sauder, J. Feldman, W. Li, F. Bozorgmehr, M. Mak, J. Smith, J. Simoes, P. Mahadevia, B.G. Anderson, T. Romero, K. Xia, G. Wang, S. Murphy, J.M. Bauml, A.I. Spira
Journal: Journal of Thoracic Oncology (2024)
P3.12D.08 DCC-3116 In Combination with Sotorasib in Advanced or Metastatic KRASG12C-Mutant Cancers: First-in-human Phase 1/2 Study
Authors: R.K. Amaravadi, D.S. Hong, C.D. Weekes, A.W. Tolcher, S. Kummar, N.V. Uboha, A. Vandross, C.M. Psoinos, M. Gozo, E. Davis, L. Viswanathan, J. Jennings, F.J. Reu, J. Mehnert
Journal: Journal of Thoracic Oncology (2024)
P2.16F.02 LIFE Project: Lung Cancer Patients' Involvement in Research Fostering Their Empowerment
Authors: B. Gaspar, X.C. Bayona, I. Brao, M. Jové, S. Lorente, M.A. Mosteiro, A. Navarro, R. Palmero, A. Sedano, E.C. Nadal
Journal: Journal of Thoracic Oncology (2024)
P4.04C.10 Validation of LungFlag™ Prediction Model Using Electronic Medical Records (EMR) On Taiwan Data
Authors: E.N. Choman, A. Lanyado, E. Israeli, N. Olghi, Y. Jin, S.-Y. Tsai, S.-Y. Liu, M. Obradovic, P.-C. Yang
Journal: Journal of Thoracic Oncology (2024)
P3.13C.06 Artificial Intelligence Meets SCLC - Integrating Clinicopathological and Whole-Slide Image Data for Prognostic Prediction in SCLC.
Authors: P. Rocha, J. Gibert, S. Menendez, R. del Rey-Vergara, A. Iñañez, L. Masfarre, N. Navarro, A. Rios-Hoyo, S. Perez, Á. Taus, M. Giner, A. Rovira, L. León-Mateos, D. Isla, L. Paz-Ares, J. Zugazagoitia, C. Martí Blanco, R. García-Campelo, A. Moreno-Vega, A. Callejo, F. Rojo, I. Sanchez, E. Arriola
Journal: Journal of Thoracic Oncology (2024)
P3.03I.13 High EGFR Expression Confers Acquired Resistance to Adagrasib - In Vitro Study Using KRASg12C Mutated Lung Cancer Cells
Authors: A. Hamada, K. Suda, K. Obata, H. Sato, H. Oiki, S. Fukuda, S. Ohara, M. Ito, J. Soh, Y. Tsutani, T. Mitsudomi
Journal: Journal of Thoracic Oncology (2024)
P3.12E.02 MEK Inhibitor Combined with RTK Inhibitor (Trametinib Plus Anlotinib) In Non-g12c KRAS-Mutant Non-Small Cell Lung Cancer: A New Strategy
Authors: B. Han, J. Lu, H. Zhong, T. Chu, W. Zhang, M. Hu, C. Shi, L. Xiong, A. Gu, H. Wang
Journal: Journal of Thoracic Oncology (2024)
P3.12D.10 Phase 1b Study of AMG 193, An MTA-Cooperative PRMT5i, Alone and in Combination with Other Therapies in MTAP-deleted NSCLC
Authors: A. Spira, A. Sacher, L. Paz-Ares Rodriguez, E. Felip, N. Reguart, I. Desar, S. Punekar, G. Dy, E. Fontana, H. Udagawa, A. El Helali, J. Menis, H.-D. Hummel, A. Itsara, T. Eggert, B. Besse
Journal: Journal of Thoracic Oncology (2024)
P3.12D.05 Furmonertinib Plus Icotinib as First-Line Treatment in EGFR-Mutated NSCLC: Updated Results in L858R and CNS Metastases Groups
Authors: H. Chen, G. Huang, T. Xia, R. Chen, M. Lin, D. Yang, Y. Luo, H. Chen, Z. Yang
Journal: Journal of Thoracic Oncology (2024)
P3.13E.01 Is Systematic Lymphadenectomy Pivotal for Bronchial Carcinoid Surgical Treatment? A TNM 9th Classification Validation Pilot Study
Authors: L. Valentini, S. Ceccarelli, M. Lugaresi, R. Potenza, P. Bertoglio, S. Bonucchi, P. Solli, F. Stella, F. Puma, N. Daddi
Journal: Journal of Thoracic Oncology (2024)
P3.13D.04 Extrachromosomal MYC-Paralogs Amplification Defines Immunosuppressive Microenvironment with Metastatic Potential in Small Cell Lung Cancer
Authors: J. Zhang, J. Deng, Y. Jin, H. Lin, K. Dai, X. Hu, K. Sun, E. Yang, X. Li
Journal: Journal of Thoracic Oncology (2024)
P3.12C.08 Surufatinib Plus Docetaxel in Patients with Relapsed Advanced Driver-Negative Non-Squamous NSCLC: A Phase Ib/II Study
Authors: W. Jiang, J. He, R. Ning, Y. Zhao, S. Zhou, L. Xu, H. Wang, S. Chen, H. Gan, J. Lin, Q.T. Yu
Journal: Journal of Thoracic Oncology (2024)
P3.08E.04 TCR Metrics as Predictive Biomarkers of Response and Survival after Perioperative Chemoimmunotherapy. NADIM &amp; NADIM II Trials
Authors: C. Martínez-Toledo, B. Sierra, M. Molina-Alejandre, M. Casarrubios, V. Calvo, E. Nadal, M.R. García Campelo, A. Martínez-Martí, A. Garrido, B. Massutí, A. Insa, J. De Castro, M. Dómine, J.L. González-Larriba, M. Majem, S. Ponce, I. Barneto, A. Aguilar, J. Martín-López, M. Provencio, A. Cruz- Bermúdez
Journal: Journal of Thoracic Oncology (2024)
P3.08F.08 NEOLA: Phase II Study of Osimertinib Treatment Before and after Chemoradiotherapy in Unresectable Stage III EGFRm NSCLC
Authors: H. Wakelee, E. Arriola, M. Chen, N. Peled, M.H. Kwint, R. Taylor, T. van der Gronde, F. Nasirova, J.V. Aredo
Journal: Journal of Thoracic Oncology (2024)
P3.03I.07 Comprehensive Pan-Cancer Analysis of Oncogenic MET Rearrangements with a Focus on Targetability in NSCLC
Authors: M. Vojnic, C.A. Febres-Aldana, I. Odintsov, T. Zhang, C.Z. Beach, D. Lu, M.S. Mattar, A. Gazzo, L. Gili, M. Harshan, A. Ameri, S. Machnicki, X. Xiao, W.W. Lockwood, X. Zhou, Q. Yao, A. Drilon, N. Rekhtman, N. Shah, A. Li, Z. Liu, S.-R. Yang, M.A. Davare, M. Ladanyi, R. Somwar
Journal: Journal of Thoracic Oncology (2024)
P3.06E.04 Genetic and Immunological Backgrounds in Advanced NSCLC Patients Treated with Immunotherapy - NGS and Flow Cytometry Analysis
Authors: N. Krzyzanowska, M. Nicoś, K. Wojas-Krawczyk, P. Krawczyk, I. Chmielewska, T. Jankowski, T. Kucharczyk, M. Wójcik-Superczyńska, A. Sroka-Bartnicka, T. Stokowy, J. Milanowski
Journal: Journal of Thoracic Oncology (2024)
P3.08E.02 An Artificial Intelligence Driven Approach to Predict Pathological Response to Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer
Authors: Y. Xia, J. Zhao, J. Zhou, X. Yan, X. Yang, J. Shou, Y. Lu, F. Yang, Y. Zhang, W. Li
Journal: Journal of Thoracic Oncology (2024)
P1.06B.10 Post-hoc Biomarker Analysis of Adebrelimab Plus Chemotherapy and Sequential Radiotherapy as First-Line Therapy for ES-SCLC
Authors: L. Wang, B. Zou, B. Li, A. Gao, W. Huang, Q. Shao, X. Meng, P. Zhang, X. Tang, X. Hu, Y. Zhang, J. Guo, L. Chin, Z. Huang, Q. Li, C. Zhu, C. Zhao, J. Yuan, J. Yu, D. Chen
Journal: Journal of Thoracic Oncology (2024)
P1.12B.10 Dose Adjustments and Exposure-Response Associated with Selpercatinib in Patients with Advanced NSCLC
Authors: K. Park, E. Arriola, M. Pérol, C. Zhou, K. Goto, H. Loong, S.S. Barker, A.C. Massey, P.M. Peterson, D. Liu, A. Akil, B. Solomon
Journal: Journal of Thoracic Oncology (2024)
P1.06B.16 HER3 Expression Across Genomic Subsets of NSCLC
Authors: B. Gupta, Y. Baca, G. Hubbard, J.E. Reuss, S.C.M. Lau, A. Elliott, M.C. Garassino, A.M. Vanderwalde, P.C. Ma, B. Halmos, S.V. Liu
Journal: Journal of Thoracic Oncology (2024)
P3.12C.06 Clinical Characteristics and Outcomes in Patients with Leptomeningeal Disease (LMD) from Non-Small Cell Lung Cancer
Authors: K. Pan, L. Hong, J. Zhang, L.A. Byers, D.L. Gibbons, J.V. Heymach, T.H. Beckham, S.D. Ferguson, X. Le
Journal: Journal of Thoracic Oncology (2024)
P1.12A.02 Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with NSCLC Harboring EGFR Exon 19 Insertions: A Report from the LC-SCRUM-Asia
Authors: Y. Uehara, H. Izumi, I.S. Kobayashi, S. Matsumoto, Y. Hosomi, T. Okuno, J. Sugisaka, N. Takase, K. Taima, S. Sasaki, S. Teranishi, S. Miyamoto, M. Mori, C. Nakashima, S. Asano, Y. Zenke, K. Yoh, D.B. Costa, S.S. Kobayashi, K. Goto
Journal: Journal of Thoracic Oncology (2024)
P3.08E.01 Perioperative Chemoimmunotherapy Rescue Cold HLA-Deficient Tumors Inducing Strong Immune Responses and Long-Term Survival
Authors: M. Molina-Alejandre, F. Perea, V. Calvo, E. Nadal, G. Huidobro, C. Martínez, A. Martínez-Martí, B. Sierra, A. Insa, B. Massutí, A. Aguilar, I. Barneto, D. Rodríguez - Abreu, J. De Castro Carpeño, M.R. García Campelo, M. Cobo, I. Wistuba, E.R. Parra, J. Martín-López, D. Megías, R. Muñoz-Viana, M. Casarrubios, F. Garrido, N. Aptsiauri, F. Ruiz-Cabello, M. Provencio, A. Cruz- Bermúdez
Journal: Journal of Thoracic Oncology (2024)
P3.12D.09 Trial in Progress: A Phase Ib Study of HMBD-001, An Anti-HER3 Antibody, in Advanced Squamous Non-Small Cell Lung Cancer
Authors: N. Pavlakis, G. Kichenadasse, G. Richardson, S. Bowyer, V. Andelkovic, V. Ganju, A. Tan, J. Samol, D. Thomas, A. Mas Fernandez, K. Paszkiewicz, P. Ingram, J. Boyd-Kirkup, K.Y. Kwek
Journal: Journal of Thoracic Oncology (2024)
P3.06D.11 Faster Treatment Decision-Making Using Liquid Biopsies NGS in Non-Small Cell Lung Cancer
Authors: C.B. Huynh, K. Brice, J. Tsai, K. Dumais, S. Almuinas, C.E. Carracedo, S.E. Musleh, N.E. Theik, P.E. Izquierdo, A.E. Alvarez, L. Drusbosky, L.E. Raez
Journal: Journal of Thoracic Oncology (2024)
P3.06D.12 Racial Differences in ALK Gene Alterations Detected by Tissue and Liquid Biopsy Across Patients with Lung Cancer
Authors: B. Potugari, F. Abu Rous, R. Gutta, E. Teslow, C. Chao, E. Jaeger, S. Gadgeel
Journal: Journal of Thoracic Oncology (2024)
P3.03I.12 Modulation of EMT Increases the Activity of Lurbinectedin in Small Cell Lung Cancer
Authors: A. Iñañez, R. del Rey-Vergara, F. Quimis, L. Masfarré, N. Navarro-Gorro, Á. Taus, A. Rovira, E. Arriola
Journal: Journal of Thoracic Oncology (2024)
P3.03J.03 Genetic Signature Derived from Single-Cell Defined Microenvironment Remodeling Correlate with Efficacy of Neoadjuvant Immunotherapy in LUSC
Authors: C. Wu, Y. Huang, L. Hou, S. Li, T. Hu, T. Sun, J. Wang, X. Li, C. Zhu
Journal: Journal of Thoracic Oncology (2024)
P3.06D.13 Patterns of Tissue NGS Alterations are Associated with ctDNA Shedding in Non Small Cell Lung Cancer Tumors Harboring EGFR Mutations
Authors: A. Di Lello, V. Torri, V. Behera, S. Wu, J.B. Hines, C.M. Bestvina, R. Thawani, J.M. Dolezal, J. Chin, A. Pezeshk, A. Esposito, M. Sacco, A.N. Husain, J. Segal, P. Wang, E. Vokes, M.C. Garassino, R.B. Cameron
Journal: Journal of Thoracic Oncology (2024)
P3.03I.19 The International Pregnancy and Lung Cancer Registry at Dana-Farber Cancer Institute
Authors: N. Florez, M. Horiguchi, O. Abioye, R. Kaufman, D. Haradon, S. Walton, R. Lederman, A. Morabito, A. Hebert, R. Camidge, L. Kiel
Journal: Journal of Thoracic Oncology (2024)
P1.08D.01 The Efficacy of Durvalumab after Concurrent Chemoradiotherapy for EGFR-Mutated Stage III Non-Small Cell Lung Cancer (NEJ063)
Authors: G. Kida, T. Fujisaki, E. Miyauchi, H. Kikuchi, F. Hommura, K. Yokoo, H. Tanaka, T. Kikuchi, D. Jingu, J. Sugisaka, K. Watanabe, N. Yoshimura, T. Nakagawa, H. Nogawa, M. Sato, K. Nakazawa, S. Soda, A. Takigami, D. Arai, K. Masubuchi, Y. Miura, Y. Miura, Y. Nagai, N. Matsumoto, T. Oba, Y. Namba, H. Ashinuma, G. Saito, M. Kamimura, S. Takahashi, K. Isobe, T. Miyawaki, K. Nishiyama, H. Sakashita, K. Nozaki, M. Inomata, Y. Umeda, K. Tateishi, S. Tetsumoto, M. Tamiya, Y. Tsubata, K. Masuda, N. Matsumoto, H. Obata, Y. Yamaji, M. Harada, H. Ohnishi, A. Nakao, S. Morita, M. Maemondo
Journal: Journal of Thoracic Oncology (2024)
P1.08C.02 Revisiting the ACS 3N2 + 1N1 Mandate: Should Old Data Define Today's Standard?
Authors: S. Gulati, R. Flores, T. Ivic-pavlicic, M. Untalan, E. Taioli, B. Housman, A. Kulshrestha
Journal: Journal of Thoracic Oncology (2024)
P1.06C.02 Description of A Single Center Thoracic Rapid Tissue Donation Program Experience
Authors: H. Ozakinci, G.S. Nazario, S. Acevedo-Acevedo, H. Trejo-Bittar, R. Macaulay, B. Pellini, J.M. Koomen, T.A. Rose, D.-T. Chen, J.K. Teer, E.R. Flores, A.A. Beg, M.B. Schabath, E.B. Haura, T.A. Boyle
Journal: Journal of Thoracic Oncology (2024)
P1.08C.03 Updated Event-Free Survival of Tislelizumab Plus Chemotherapy Asneoadjuvant/adjuvant Therapy for Stage IIB-IIIC NSCLC (lungmark Study)
Authors: Y.-B. Lin, Y.-H. Chen, Z.-C. Lin, M. Zhou, W.-Y. Zhai, Y.-H. Zhou, S.-C. Feng, B.-Y. Rao, M. Huang, H. Long
Journal: Journal of Thoracic Oncology (2024)
P1.08C.05 The Clinicopathological and Prognostic Significance of Skip-N2 Metastases: A Retrospective Multicenter Study
Authors: K. Suzawa, T. Ryuko, K. Shien, M. Okazaki, T. Ueno, M. Yamashita, Y. Maki, T. Fujiwara, M. Watanabe, H. Inokawa, Y. Shikatani, T. Misao, K. Washio, H. Torigoe, Y. Hirami, H. Tao, M. Hayama, D. Okutani, S. Otani, Y. Sano, Y. Tomioka, M. Muro, M. Uomoto, T. Kurosaki, E. Niman, K. Takahashi, H. Yaginuma, O. Kawamata, T. Yoshikawa, T. Ohtsuka, H. Nishkawa, D. Hayashi, T. Hayashi, S. Toyooka
Journal: Journal of Thoracic Oncology (2024)
P1.09B.04 Impact of BMI on TTFields in Patients with Mnsclc: Post-hoc Analysis from the Phase 3 LUNAR Study and Simulation Model Data
Authors: C. Rolfo, D.E. Gerber, R. Kotecha, J. Ward, W. Akerley, A. Naveh, N. Shapira, T. Leal, C. Langer
Journal: Journal of Thoracic Oncology (2024)
P1.09B.01 Surgical Reduction at the Peak of Response Before Disease Progression in Patients with Metastatic EGFR-Mutated Lung Cancer
Authors: F.V. Moiseenko, D. Stroyakovskiy, E. Levchenko, M. Fedyanin, A. Gabina, A. Danilova, A. Allakhverdiev, E. Stepanova, A. Oganesian, S. Belukhin, M. Stepanova, E. Artemeva, A. Myslik, N. Volkov, A. Bogdanov, T. Shuginova, K. Krukov, V. Khenshtein, I. Zaberezhny, N. Levchenko, E. Slugin, O. Lopushanskaya, E. Kuligina, S. Aleksakhina, A. Iyevleva, A. Ivantsov, N. Savelov, D. Sehniaidze, Y. Akhmadiyarova, M. Popov, E. Imyanitov, V. Moiseyenko
Journal: Journal of Thoracic Oncology (2024)
P3.03I.10 RRAS and RRAS2 Mutations Are Oncogenic Drivers in Lung Cancer and are Sensitive to the Pan-RAS Inhibitor RMC-6236
Authors: A.J. Pfeil, T. Zhang, C.A. Febres-Aldana, R. Cheng, M.S. Mattar, K. Arbour, M. Ladanyi, S.-R. Yang, R. Somwar
Journal: Journal of Thoracic Oncology (2024)
P1.12B.03 Real-World Outcomes of 2L ALK TKIs Following 1L Brigatinib for Patients with ALK+ NSCLC from the ALTA-1L Trial
Authors: M.-J. Ahn, A. Delmonte, S. Ghosh, M. Hochmair, T.-Y. Yang, J.C.-H. Yang, J.-Y. Han, K. Holmskov Hansen, Y. Wu, Y. Wan, H.M. Lin, J. Kretz, B. Hupf, A.M. Kurec, E.N. Churchill, R.J. Fram, C.J. Cabasag, V. Goriya, Y. Zhao, E. Gemmen, M.R. García Campelo
Journal: Journal of Thoracic Oncology (2024)
P1.06B.06 Analysis of Antibody-Drug Conjugate Target Expression Across Genomic Subsets of Non-Small Cell Lung Cancer
Authors: J.J. Lin, B.Y. Yeap, J.L. Peterson, A. Do, M.K. Banwait, J. Schwartz, M.L. Ganci, A.N. Hata, R.S. Heist, Z. Piotrowska, J.F. Gainor, M. Mino-Kenudson
Journal: Journal of Thoracic Oncology (2024)
P1.12A.07 A Phase 1 Study of TY-9591 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR Positive Mutation.
Authors: B. Han, W. Zhang, L. Wu, B. Chen, Y. Zhao, J. Liu, J. He, Y. Liu, Z. Zhang, H. Chen, X. Chen, Y. Wu
Journal: Journal of Thoracic Oncology (2024)
P3.03I.08 Efficacy of Novel Third-Generation Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations- Anin Vitrostudy
Authors: H. Oiki, K. Suda, A. Hamada, K. Obata, K. Sakai, T. Fujino, S. Fukuda, S. Ohara, M. Ito, J. Soh, K. Nishio, T. Mitsudomi, Y. Tsutani
Journal: Journal of Thoracic Oncology (2024)
P2.11C.01 With Eyes on the Future: Prospective Evaluation of Immune-Related Adverse Events in Patients with Lung Cancer
Authors: L. Kiel, R. Kaufman, M. Horiguchi, D. Haradon, M. Sanchez, R. Lederman, F. Amaral Duarte, K. Meza, C. Mantz, T. Nguyen, S. McDonald, E. Sharon, N. Florez (Duma)
Journal: Journal of Thoracic Oncology (2024)
P1.03D.05 A Novel DNA Repair-Gene Model to Predict Responses to Immunotherapy and Prognosis in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
Authors: F. Wang, X-w. Wei, M-y. Yang, C. Lu, X-r. Yang, J-y. Deng, Z-h. Chen, Q. Zhou
Journal: Journal of Thoracic Oncology (2024)
P2.11A.27 Generalizability of Radiomics Based Progression Risk Models in Immunotherapy Treated Mnsclc Subjects
Authors: J.W.H. Gordon, H. Moudgalya, J. Raya, N. Otto, A. Poles, M.C. Stumpe, M.J.J. Fidler, K. Nagpal, M. Codari, J.A. Borgia
Journal: Journal of Thoracic Oncology (2024)
P1.06B.09 Noninvasive Blood Biopsy of CRTAM-Type 3 Immune Axis Enables Dynamic Monitoring of Iraes Over the Course of Immunotherapy in Lung Cancer
Authors: S.-C. Ma, Z.-X. Rong, J.-R. Lin, Z.-P. Xu, D.-H. Wu, Z.-Y. Dong
Journal: Journal of Thoracic Oncology (2024)
P2.16G.02 "It's Like A Donut!"- Veteran Perspectives of Lung Cancer Screening with Low Dose CT
Authors: C.A. Castagna-McLeod, H. Brooks, K. Bonnet, D. Schlundt, S. York, F. Hendler, S. Byerly, C. Audet, D. Moghanaki, R. Dittus, C. Roumie, J. Lewis, L. Spalluto
Journal: Journal of Thoracic Oncology (2024)
P1.09A.03 Concurrent Combination of EGFR-TKIs and Thoracic Radiation Therapy for Metastatic Non Small Cell Lung Cancer Patients
Authors: M. Yoshida, T. Fujii, K. Shida, C. Osumi, T. Fujii, A. Kawata, T. Kishigami, Y. Nishimoto, M. Hasegawa, M. Kikuchi, T. Gomi
Journal: Journal of Thoracic Oncology (2024)
P1.06B.05 Utility of Molecular Tumor Board Driven by Precision Medicine Service and Cloud-Based Datamart for Therapy and Trial Matching
Authors: J.K. Hicks, A. Saltos, A. Aminpour, A. Chiappori, H. Ozakinci, D.E. Rollison, P. Reisman, J. Creed, T.A. Boyle, G.R. Simon, J.E. Gray
Journal: Journal of Thoracic Oncology (2024)
P1.03G.01 Lurbinectedin Synergizes with Selinexor by Inhibiting DNA Damage Repair and Enhancing Immune Cell Infiltration in Neuroendocrine Lung Tumors
Authors: E. Redin, P. Manoj, J. Qiu, H. Zhong, S. Vural, Y. Zhan, R. Koche, N. Socci, E. DeStanchina, C.M. Rudin, A. Quintanal-Villalonga
Journal: Journal of Thoracic Oncology (2024)
P1.03F.03 Utility of Patient-Derived Xenograft and Xenograft-Derived Organoid Models with EGFR Mutation to Study EGFR-TKI Resistance.
Authors: T. Koga, N.-A. Pham, J. Rosen, Q. Li, A. Arivajiagane, K. Hueniken, S. Khan, M. Khalil, N. Radulovich, F.A. Shepherd, K. Yasufuku, G. Liu, M.-S. Tsao
Journal: Journal of Thoracic Oncology (2024)
P2.14B.03 A Phase II Parallel Arm Study of Sacituzumab Govitecan-Hziy in Patients with Advanced Thymoma and Thymic Carcinoma
Authors: J.A. Marks, S. Agarwal, J. Ahn, J.E. Reuss, M. Altan, C. Nabel, M.E. Gutierrez, M.C. Garassino, G.J. Riely, H. Wakelee, S.V. Liu, C. Kim
Journal: Journal of Thoracic Oncology (2024)
P1.06A.04 Deep Learning-based Whole Slide Image Analysis Predicts PD-L1 Status from H&amp;E-Stained Histopathology Images in Lung Cancer
Authors: Y.-F. Qi, W.-Y. Huang, J.-C. Liang, Z.-X. Zhou, Z.-B. Qiu, C. Zhang, Y.-L. Wu, W.-Z. Zhong
Journal: Journal of Thoracic Oncology (2024)
P2.11A.26 Prognostic Utility of Peripheral Myeloid Cells for Clinical Outcomes in Patients with NSCLC Treated with Cemiplimab
Authors: R.J. Acosta, D.A.G. McIntyre, J.C. Murray, V. Anagnostou, J.R. Brahmer, A. Meisel, A. Sezer, M. Gogishvili, T. Melkadze, A. Baramidze, T. Makharadze, F. Seebach, P. Rietschel, J.-F. Pouliot, Y. Kim
Journal: Journal of Thoracic Oncology (2024)
P2.14A.12 Unveiling COL17A1 as a Novel Cell Surface Target in Thymic Epithelial Tumors: A Target Discovery Pipeline Approach
Authors: F. Ardeshir Larijani, F. Perna, H. Mesa, V.A. DeBrock, T. Alby Augustine, L.A. Baldrige, E. Liu, T. Hou, A. Cesarano, H. Gao, Y. Liu, F. Fang, P. Christopher, R. Maniar, T.S. Johnson, D. Chatterjee, P.J. Loehrer
Journal: Journal of Thoracic Oncology (2024)
P2.14A.10 Real-World Evidence of Ipilimumab Plus Nivolumab Combination Therapy in Patients with Malignant Pleural Mesothelioma
Authors: T. Kondo, T. Otsuki, M. Kato, T. Murata, M. Mori, H. Ota, H. Wakita, T. Kandori, J. Kiyota, T. Higashiyama, M. Tokuda, A. Tada, Y. Negi, D. Horio, D. Fujimoto, K. Mikami, R. Takahashi, T. Minami, K. Kuribayashi, T. Kijima
Journal: Journal of Thoracic Oncology (2024)
P1.06B.07 Association of NEDD9 Expression and Survival of Patients with KRAS Mutant and STK11 Mutant Non-Small Cell Lung Cancer (KRASMUT/STK11MUT-NSCLC)
Authors: J. Judd, N. Gandhi, J. Xiu, A. Deneka, H. Khan, N.A. Karim, S.V. Liu, A.R. Naqash, H. Borghaei, E. Golemis, G. Hemenway
Journal: Journal of Thoracic Oncology (2024)
P2.11A.23 Fecal Microbiota Transplantation Plus Rechallenging Immunotherapy in Patients with Advanced Non Small Cell Lung Cancer: An Exploratory Study
Authors: M.J. Huang, Y.j. Du, Y. Li, M. Yu, Y. Yu, Y. Zhang, Y. Lu, L. Li, J. He, Y. Gong, J. Zhu, B. Zou, Y. Liu
Journal: Journal of Thoracic Oncology (2024)
P1.06C.06 The Prognostic Impacts of Three Invasive Patterns in Pulmonary Peripheral Squamous Cell Carcinoma
Authors: H. Iguchi, Y. Hirai, T. Nakaya, A. Fusamoto, Y. Yata, Y. Mikasa, I. Matsuzaki, I. Hirai, S.-I. Murata, Y. Nishimura
Journal: Journal of Thoracic Oncology (2024)
P1.03C.01 A Landscape of the Driver Alterations in 920 Brazilian Lung Cancer Patients
Authors: R. De Oliveira Cavagna, F. Escremim de Paula, G. Noriz Berardinelli, M. Bonatelli, I. Santana, G. Ramos Teixeira, B. Garbe Zaniolo, J. Mourão Dias, F.A. Ferreira da Silva, C.E. Baston Silva, M. Gondim Borges Guimarães, C. Pinto Barone, M. Xavier Reis, E. Lopes Maia, T. Santos de Alencar, R. Martins Queiroz Barbosa, F.H. de Queiroz, I. Marriel Ramos Novais, J. Favoreto Neto, A.A. Jacinto, L. Ferreira, G. Severino Bueno, R.E. Noleto da Nóbrega Oliveira, J.E. Miziara, P. de Marchi, M.A. Molina-Vila, L. Ferro Leal, R.M. Reis
Journal: Journal of Thoracic Oncology (2024)
P1.06B.01 NSCLC in Patients with CTD-ILD: Apobec-Related Mutagenesis, Frequent TP53 Mutations and Paucity of Targetable Alterations
Authors: I. Odintsov, M.M. Hammer, M.M. Awad, P.F. Dellaripa, L.M. Sholl
Journal: Journal of Thoracic Oncology (2024)